Accueil / Formation Recherche / Publications / Publications Histiocytoses

Publications Histiocytoses

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.

Response to trametinib of histiocytosis with an activating PTPN11 mutation.

Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis.

Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langerhans Cell Histiocytosis.

Erdheim-Chester Disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1.

RASA1 loss in a BRAF-mutated Langerhans cell sarcoma: a mechanism of resistance to BRAF inhibitor.

Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors.

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.

Highly sensitive methods are required to detect mutations in histiocytoses

Langerhans Cell Histiocytoma: A Benign Histiocytic Neoplasm of Diverse Lines of Terminal Differentiation.

Long-bones involvement in generalized crystal-storing histiocytosis.

Glomeruloid haemangioma: a possible consequence of elevated VEGF in POEMS and Erdheim-Chester disease.

Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.

Cladribine-related immunosuppression may have fostered graft-versus-host disease after lung transplant for pulmonary Langerhans cell histiocytosis.


Highly sensitive methods are required to detect mutations in histiocytoses.

Langerhans Cell Histiocytoma: A Benign Histiocytic Neoplasm of Diverse Lines of Terminal Differentiation.

Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment.

Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.

BRAF V600E mutation detected in a case of Rosai-Dorfman disease.

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Phenotypes and survival in Erdheim-Chester disease: results from a 165-patient cohort


Efficacy of infliximab in the treatment of Erdheim-Chester disease.

How I manage pulmonary Langerhans cell histiocytosis. Lorillon G et al. Eur Respir Rev. 2017 Sep 6;26(145).

Current understanding and management of pulmonary Langerhans cell histiocytosis. Vassallo R et al. Thorax. 2017 Oct;72(10):937-945.

Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study. Tazi A et al.  Orphanet J Rare Dis. 2017 May 22;12(1):95.

New somatic BRAF splicing mutation in Langerhans cell histiocytosis. Héritier S et al. Mol Cancer. 2017 Jul 6;16(1):115.

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis. Héritier S et al. Br J Haematol. 2017 Aug;178(3):457-467.

Erdheim-Chester disease: the “targeted” revolution. Vaglio A et al. Blood. 2017 Sep 14;130(11):1282-1284.

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Durham BH et al. Blood. 2017 Jul 13;130(2):176-180.

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study). Cohen Aubart F et al. Blood. 2017 Sep 14;130(11):1377-1380.

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis. Papo M et al. Blood. 2017 Aug 24;130(8):1007-1013.

Histiocytoses langerhansienne de l'adulte La Revue de Médecine Interne ; 36(10):658-67 ; Octobre 2015

The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study.


 

ACTUALITÉS

Nouveau cas clinique "Amylose AL"
Testez vos connaissances
Le congrès des Rencontres RARE revient pour sa 6ème édition, les 5 & 6 novembre 2019
Cité des Sciences et de l'Industrie, Paris
Les nouvelles recommandations nationales de prises en charge des aplasies médullaires sont en ligne
Nouveau Protocole National de Diagnostic et de Soins 2019 sur le site de la HAS !
Voir toutes les actualités